Skip to main content
Header Menu
University of California San Francisco
UCSF Medical Center
Search UCSF
About UCSF
Search
Give
NATIONAL NEWSLETTER SIGNUP
CALIFORNIA NEWSLETTER SIGNUP
(877) 509-3786
Want Technical Assistance?
About Us
Staff
News
Newsletter & Listserv Signup
California Center for Tobacco Cessation: The CA CTC Newsletter
Communiqué Newsletter
Director's Corner
Events
Support Us
Partnerships & Collaborations
California Center for Tobacco Cessation (CaCTC)
National Behavioral Health Network
The National Partnership on Behavioral Health and Tobacco Use
SAMHSA
Pfizer IGLC
Smoke-Free Public Housing: Helping Smokers Quit
UC Quits
Behavioral Health
Curricula & Online Training
Fact Sheets & Reports
Presentations
Publications
Toolkits
Priority Populations
People Experiencing Homelessness
Justice Involved
LGBTQIA+ Populations
Race/Ethnicity
Resources
Asian Smokers' Quitline
Campaigns & Initiatives
Comments Submitted
Curricula & Online Training
Fact Sheets & Reports
Infographics & Calculator
Publications
Presentations
1-800-QUIT-NOW cards
Toolkits
Spiral Up Lite (©2024 EBT, Inc.)
Videos
Webinars
CME/CE Credit for Webinar Collections
Individual Recordings Available for CME/CE Credit
Webinar Archive
QUIT
Social Support
Treatment Options
Online Resources
Medications
Quitline
Breadcrumb
Home
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
Anthenelli, R.M., Benowitz, N.L., et al.
January 1, 2016